These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36940228)

  • 21. Retrospective study of toxoplasmosis prevalence in pregnant women in Benin and its relation with malaria.
    Dambrun M; Dechavanne C; Guigue N; Briand V; Candau T; Fievet N; Lohezic M; Manoharan S; Sare N; Viwami F; Simon F; Houzé S; Migot-Nabias F
    PLoS One; 2022; 17(1):e0262018. PubMed ID: 34995295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Awareness, knowledge and risk factors of
    Eroglu S; Asgin N
    J Obstet Gynaecol; 2021 Jul; 41(5):714-720. PubMed ID: 33045851
    [No Abstract]   [Full Text] [Related]  

  • 23. Toxoplasma gondii seroprevalence in Mali.
    Ouologuem DT; Djimdé AA; Diallo N; Doumbo OK; Roos DS
    J Parasitol; 2013 Apr; 99(2):371-4. PubMed ID: 22924926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toxoplasma gondii antibody profile in HIV-infected pregnant women and the risk of congenital toxoplasmosis.
    Lago EG; Conrado GS; Piccoli CS; Carvalho RL; Bender AL
    Eur J Clin Microbiol Infect Dis; 2009 Apr; 28(4):345-51. PubMed ID: 18855029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retrospective Evaluation of the Seropositivity Rate of Toxoplasmosis and Clinical Results in Pregnant Women That were Admitted to a Tertiary Health Institution Between 2012 and 2017 in Turkey.
    Durukan H; Çevikoğlu Kıllı M
    Turkiye Parazitol Derg; 2019 Sep; 43(3):106-110. PubMed ID: 31502771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing toxoplasma seropositivity in women with bad obstetric history and in newborns.
    Sharma P; Gupta I; Ganguly NK; Mahajan RC; Malla N
    Natl Med J India; 1997; 10(2):65-6. PubMed ID: 9153982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Seroepidemiology of toxoplasmosis in pregnant women since the implementation of the Surveillance Program of Toxoplasmosis Acquired in Pregnancy and Congenital in the western region of Paraná, Brazil].
    Bittencourt LH; Lopes-Mori FM; Mitsuka-Breganó R; Valentim-Zabott M; Freire RL; Pinto SB; Navarro IT
    Rev Bras Ginecol Obstet; 2012 Feb; 34(2):63-8. PubMed ID: 22437764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence and incidence of Toxoplasma antibodies in pregnant women.
    Franklin DM; Dror Z; Nishri Z
    Isr J Med Sci; 1993 May; 29(5):285-6. PubMed ID: 8314688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening programme for congenital toxoplasmosis in France.
    Thulliez P
    Scand J Infect Dis Suppl; 1992; 84():43-5. PubMed ID: 1290073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxoplasmosis in pregnancy: prevention, screening, and treatment.
    Paquet C; Yudin MH;
    J Obstet Gynaecol Can; 2013 Jan; 35(1):78-81. PubMed ID: 23343802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Identification of risk factors for infection with Toxoplasma gondii in Serbia as a basis of a program for prevention of congenital toxoplasmosis].
    Bobić B; Nikolić A; Djurković-Djaković O
    Srp Arh Celok Lek; 2003; 131(3-4):162-7. PubMed ID: 14608881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of congenital toxoplasmosis in a Buenos Aires hospital].
    Carral L; Kaufer F; Olejnik P; Freuler C; Durlach R
    Medicina (B Aires); 2013; 73(3):238-42. PubMed ID: 23732199
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toxoplasmosis in the fetus and newborn: an update on prevalence, diagnosis and treatment.
    Moncada PA; Montoya JG
    Expert Rev Anti Infect Ther; 2012 Jul; 10(7):815-28. PubMed ID: 22943404
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxoplasmosis screening during pregnancy in France: Opinion of an expert panel for the CNGOF.
    Picone O; Fuchs F; Benoist G; Binquet C; Kieffer F; Wallon M; Wehbe K; Mandelbrot L; Villena I
    J Gynecol Obstet Hum Reprod; 2020 Sep; 49(7):101814. PubMed ID: 32428782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active control of congenital toxoplasmosis in the population.
    Palicka P; Slabá H; Zitek K
    Cent Eur J Public Health; 1998 Nov; 6(4):265-8. PubMed ID: 9919374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxoplasma gondii infection in Kyrgyzstan: seroprevalence, risk factor analysis, and estimate of congenital and AIDS-related toxoplasmosis.
    Minbaeva G; Schweiger A; Bodosheva A; Kuttubaev O; Hehl AB; Tanner I; Ziadinov I; Torgerson PR; Deplazes P
    PLoS Negl Trop Dis; 2013; 7(2):e2043. PubMed ID: 23409201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis.
    Pappas G; Roussos N; Falagas ME
    Int J Parasitol; 2009 Oct; 39(12):1385-94. PubMed ID: 19433092
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of congenital toxoplasmosis in Szeged, Hungary.
    Szénási Z; Ozsvár Z; Nagy E; Jeszenszky M; Szabó J; Gellén J; Végh M; Verhofstede C
    Int J Epidemiol; 1997 Apr; 26(2):428-35. PubMed ID: 9169181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The program for antenatal screening of toxoplasmosis in Finland: a prospective cohort study.
    Koskiniemi M; Lappalainen M; Koskela P; Hedman K; Ammälä P; Hiilesmaa V; Teramo K
    Scand J Infect Dis Suppl; 1992; 84():70-4. PubMed ID: 1290079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serological survey and risk factors associated with
    Zakari MM; Isah AY; Offiong R; Yunusa T; Abdullahi IN
    Malawi Med J; 2020 Sep; 32(3):160-167. PubMed ID: 33488988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.